SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-20-000041
Filing Date
2020-01-16
Accepted
2020-01-16 08:00:30
Documents
1
Group Members
DRW HOLDINGS, LLCDRW MANAGEMENT LLCDRW VENTURE CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 e619288_sc13g-artara.htm SC 13G 96630
  Complete submission text file 0001193805-20-000041.txt   98082
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88372 | Film No.: 20529455
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 540 W. MADISON ST., SUITE 2500 CHICAGO IL 60661
Business Address
Wilson Donald R. Jr. (Filed by) CIK: 0001565352 (see all company filings)

Type: SC 13G